Faisal Alotaibi. (2023). Naringenin alters the pharmacokinetics of ranolazine in part through the inhibition of cytochrome P450 (3A4) and P-glycoprotein. SpringerOpen.
Chicago Style (17th ed.) CitationFaisal Alotaibi. Naringenin Alters the Pharmacokinetics of Ranolazine in Part Through the Inhibition of Cytochrome P450 (3A4) and P-glycoprotein. SpringerOpen, 2023.
MLA (9th ed.) CitationFaisal Alotaibi. Naringenin Alters the Pharmacokinetics of Ranolazine in Part Through the Inhibition of Cytochrome P450 (3A4) and P-glycoprotein. SpringerOpen, 2023.
Warning: These citations may not always be 100% accurate.